477 related articles for article (PubMed ID: 17851245)
41. Profile of young people attending alcohol and other drug treatment services in Aotearoa, New Zealand: clinical file search.
Schroder R; Sellman D; Frampton C; Deering D
Aust N Z J Psychiatry; 2008 Nov; 42(11):963-8. PubMed ID: 18941961
[TBL] [Abstract][Full Text] [Related]
42. Treatments for patients with dual diagnosis: a review.
Tiet QQ; Mausbach B
Alcohol Clin Exp Res; 2007 Apr; 31(4):513-36. PubMed ID: 17374031
[TBL] [Abstract][Full Text] [Related]
43. A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs.
Wittchen HU; Behrendt S; Höfler M; Perkonigg A; Rehm J; Lieb R; Beesdo K
Drug Alcohol Depend; 2009 Jun; 102(1-3):151-7. PubMed ID: 19362792
[TBL] [Abstract][Full Text] [Related]
44. Beyond treatment effects: predicting emerging adult alcohol and marijuana use among substance-abusing delinquents.
Clingempeel WG; Henggeler SW; Pickrel SG; Brondino MJ; Randall J
Am J Orthopsychiatry; 2005 Oct; 75(4):540-52. PubMed ID: 16262513
[TBL] [Abstract][Full Text] [Related]
45. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
46. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
Thoma P; Daum I
Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
[TBL] [Abstract][Full Text] [Related]
47. Management of schizophrenia with substance use disorders.
Lybrand J; Caroff S
Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
[TBL] [Abstract][Full Text] [Related]
48. Borderline personality and substance use in women.
Feske U; Tarter RE; Kirisci L; Pilkonis PA
Am J Addict; 2006; 15(2):131-7. PubMed ID: 16595350
[TBL] [Abstract][Full Text] [Related]
49. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.
Brunette MF; Drake RE; Xie H; McHugo GJ; Green AI
Schizophr Bull; 2006 Oct; 32(4):637-43. PubMed ID: 16782758
[TBL] [Abstract][Full Text] [Related]
50. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.
Schaub M; Fanghaenel K; Stohler R
Aust N Z J Psychiatry; 2008 Dec; 42(12):1060-5. PubMed ID: 19016094
[TBL] [Abstract][Full Text] [Related]
51. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
Kalyoncu A; Mirsal H; Pektas O; Unsalan N; Tan D; Beyazyürek M
J Psychopharmacol; 2005 May; 19(3):301-5. PubMed ID: 15888516
[TBL] [Abstract][Full Text] [Related]
52. Prospective validation of substance abuse severity measures from administrative data.
McCamant LE; Zani BG; McFarland BH; Gabriel RM
Drug Alcohol Depend; 2007 Jan; 86(1):37-45. PubMed ID: 16806738
[TBL] [Abstract][Full Text] [Related]
53. Reasons for increased substance use in psychosis.
Gregg L; Barrowclough C; Haddock G
Clin Psychol Rev; 2007 May; 27(4):494-510. PubMed ID: 17240501
[TBL] [Abstract][Full Text] [Related]
54. Six-month treatment outcomes of cocaine-dependent patients with and without PTSD in a multisite national trial.
Najavits LM; Harned MS; Gallop RJ; Butler SF; Barber JP; Thase ME; Crits-Christoph P
J Stud Alcohol Drugs; 2007 May; 68(3):353-61. PubMed ID: 17446974
[TBL] [Abstract][Full Text] [Related]
55. [The significance of psychotropic substance abuse and addiction in the treatment of psychosomatic rehabilitation patients].
Wiehn T; Domma J; Vollmer HC
Rehabilitation (Stuttg); 2008 Jun; 47(3):158-63. PubMed ID: 18553246
[TBL] [Abstract][Full Text] [Related]
56. [Severe depression and addictions].
Cottencin O
Encephale; 2009 Dec; 35 Suppl 7():S264-8. PubMed ID: 20141784
[TBL] [Abstract][Full Text] [Related]
57. [Social competencies of persons with a dual diagnosis--literature review].
Spiridonow K; Orzechowska Z
Psychiatr Pol; 2007; 41(1):53-61. PubMed ID: 17494414
[TBL] [Abstract][Full Text] [Related]
58. Comorbid schizophrenia and substance abuse.
Green AI; Brown ES
J Clin Psychiatry; 2006 Sep; 67(9):e08. PubMed ID: 17081075
[TBL] [Abstract][Full Text] [Related]
59. Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments.
Karterud S; Arefjord N; Andresen NE; Pedersen G
Nord J Psychiatry; 2009; 63(1):57-63. PubMed ID: 19172500
[TBL] [Abstract][Full Text] [Related]
60. Current research on co-occurring substance-use disorder in schizophrenia.
Drake RE; Green AI
Schizophr Bull; 2006 Oct; 32(4):616-7. PubMed ID: 16896056
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
